These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20540088

  • 1. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation.
    Martin PL, Sachs C, Imai N, Tsusaki H, Oneda S, Jiao Q, Treacy G.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088
    [Abstract] [Full Text] [Related]

  • 2. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
    Enright BP, Tornesi B, Weinbauer GF, Blaich G.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
    [Abstract] [Full Text] [Related]

  • 3. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.
    Katagiri R, Ishihara-Hattori K, Frings W, Amano J, Fuchs A, Chiba S.
    Birth Defects Res; 2017 Jul 03; 109(11):843-856. PubMed ID: 28504465
    [Abstract] [Full Text] [Related]

  • 4. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
    Vaidyanathan A, McKeever K, Anand B, Eppler S, Weinbauer GF, Beyer JC.
    Toxicol Sci; 2011 Jan 03; 119(1):116-25. PubMed ID: 20937725
    [Abstract] [Full Text] [Related]

  • 5. Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system.
    Martin PL, Oneda S, Treacy G.
    Am J Reprod Immunol; 2007 Aug 03; 58(2):138-49. PubMed ID: 17631007
    [Abstract] [Full Text] [Related]

  • 6. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys.
    Clarke DO, Hilbish KG, Waters DG, Newcomb DL, Chellman GJ.
    Reprod Toxicol; 2015 Dec 03; 58():160-73. PubMed ID: 26482726
    [Abstract] [Full Text] [Related]

  • 7. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2015 Jun 03; 104(3):100-16. PubMed ID: 26195230
    [Abstract] [Full Text] [Related]

  • 8. Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Oneda S, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 03; 86(2):117-30. PubMed ID: 19278014
    [Abstract] [Full Text] [Related]

  • 9. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 03; 86(2):144-56. PubMed ID: 19283860
    [Abstract] [Full Text] [Related]

  • 10. The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates, and group size considerations.
    Jarvis P, Srivastav S, Vogelwedde E, Stewart J, Mitchard T, Weinbauer GF.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Jun 03; 89(3):175-87. PubMed ID: 20544806
    [Abstract] [Full Text] [Related]

  • 11. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
    Weisenburger WP, Hagler AR, Tassinari MS.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun 03; 71(3):171-84. PubMed ID: 15282738
    [Abstract] [Full Text] [Related]

  • 12. Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune system.
    Martin PL, Cornacoff JB, Treacy G, Eirikas E, Marini J, White KL, Peachee V, Hoberman A.
    Int J Toxicol; 2008 Jun 03; 27(4):341-7. PubMed ID: 18821398
    [Abstract] [Full Text] [Related]

  • 13. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator.
    Auyeung-Kim DJ, Devalaraja MN, Migone TS, Cai W, Chellman GJ.
    Reprod Toxicol; 2009 Dec 03; 28(4):443-55. PubMed ID: 19631735
    [Abstract] [Full Text] [Related]

  • 14. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
    Bowman CJ, Chmielewski G, Oneda S, Finco D, Boucher MA, Todd M.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug 03; 89(4):326-38. PubMed ID: 20540090
    [Abstract] [Full Text] [Related]

  • 15. The enhanced pre- and postnatal development study for monoclonal antibodies.
    Weinbauer GF, Luft J, Fuchs A.
    Methods Mol Biol; 2013 Aug 03; 947():185-200. PubMed ID: 23138905
    [Abstract] [Full Text] [Related]

  • 16. Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis).
    Bowman CJ, Evans M, Cummings T, Oneda S, Butt M, Hurst S, Gremminger JL, Shelton D, Kamperschroer C, Zorbas M.
    Reprod Toxicol; 2015 Jun 03; 53():105-18. PubMed ID: 25461901
    [Abstract] [Full Text] [Related]

  • 17. Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions.
    Brodmerkel C, Zhu Y, Jiao Q, Cornacoff J, Treacy G, Mascelli MA, Gottlieb AB.
    J Drugs Dermatol; 2010 Jun 03; 9(6):677-83. PubMed ID: 20645530
    [Abstract] [Full Text] [Related]

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 03; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 19. Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions.
    Martin PL, Weinbauer GF.
    Int J Toxicol; 2010 Dec 03; 29(6):552-68. PubMed ID: 20926830
    [Abstract] [Full Text] [Related]

  • 20. Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option.
    Stewart J.
    Reprod Toxicol; 2009 Sep 03; 28(2):220-5. PubMed ID: 19379807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.